This study analyzed the ability of the N-meth yl-D-aspartate receptor antagonist dextrorphan (DX) to prevent neuronal degeneration (analyzed by light micros copy), calmodulin (CaM) redistribution (analyzed by im munocytochemistry) and changes in activity of two major Ca 2 + -dependent protein kinases-calcium/calmodulin dependent protein kinase II (CaM-KII) and protein kinase C (PKC) (analyzed by specific substrate phosphorylation) after 20 min of global ischemia (four-vessel occlusion model) in rats. DX treatment before and after ischemia significantly protected hippocampal and cortical neurons from neurodegeneration whereas DX posttreatment alone
Increase in intracellular Ca2 + is recognized as an important step leading to excitotoxic neuronal de generation (Choi, 1988a; Siesj6 and Bengtsson, 1989) . A reduction in brain blood supply leads to anoxia and aglycemia of neuronal tissue. This re sults in the release of abnormally large amounts of L-glutamate and L-aspartate which then lead to ac tivation of postsynaptic glutamate receptors (Ben veniste et aI., 1984) . One of the glutamate receptor subtypes named after the selective agonist N-meth yl-D-aspartate (NMDA) is a voltage-dependent and did not have any effect on preservation of neuronal mor phology as compared with placebo treatment analyzed 72 h after 20 min of ischemia. Similarly to histological changes, DX exhibited protection against redistribution of CaM observed after ischemia. These changes were de tected both in hippocampus as well as in cerebral cortex. Finally, DX administered before ligation of the carotid arteries reduced loss in both CaM-KII and PKC activity evoked by ischemia. Key Words: Brain-Ischemia Glutamate-Dextrorphan-Neuronal death-Phosphor ylation.
ligand-gated ion channel (Collingridge and Lester, 1989; Yoneda and Ogita, 1991) . This receptor, un like non-NMDA glutamate receptors, is permeable to Ca2+ and is regulated by multiple factors, as re cently reviewed (Collingridge and Lester, 1989) . Stimulation of NMDA receptors by massively re leased glutamate during ischemia allows Ca2+ to enter neurons thus contributing to an overload of cytosolic Ca2+ and neuronal death (Kudo and Ogura, 1986; MacDermot et aI., 1986) . Substances such as MK-801, phencyclidine (PCP), ketamine, or dextrorphan (DX) represent a group of NMDA re ceptor antagonists which are noncompetitive with respect to glutamate (Collingridge and Lester, 1989) . Unlike competitive antagonists (like CGS 19755) which prevent ion influx through the channel by binding to the same site as glutamate, noncom petitive antagonists are thought to block Ca2+ flux through the receptor by binding to distinct sites within the open channel (Lehmann et aI., 1988) . Glutamate can also increase the concentration of intracellular Ca2 + indirectly, through activation of non-NMDA glutamate receptors. Activated non NMDA receptors cause depolarization of the cell membrane which in turn opens voltage-gated Ca2+ channels resulting in Ca2 + influx. Finally, gluta mate through interaction with the metabotropic re ceptor evokes release of Ca2 + from intracellular stores (Mayer and Miller, 1990) .
Intracellular rises in Ca2+ concentration modu late the functional state of several neuronal en zymes, receptors, and membrane ion channels which help to maintain intracellular homeostasis re quired for cell integrity (Kennedy, 1989) . Disrup tion of this homeostasis by an overload of Ca2 + during ischemia disrupts mUltiple cellular biochem ical processes which subsequently leads to neuro toxic injury and neuronal death (Choi, 1988b) . Sev eral enzymes have been postulated to be responsi ble for Ca2 + -mediated neuronal injury, including Ca2+ -regulated proteases, phospholipases, and ki nases. Multiple Ca2+ effects, including regulation of some of the above enzymes, are mediated through the Ca2 + -binding protein calmodulin (CaM). In fact, in an earlier study we showed that immunostaining of free calmodulin (unbound to Ca2+ and target protein) after forebrain ischemia was decreased in regions of the brain most vulner able to ischemia by histopathological criteria (Pi cone et aI., 1989) . Decreases in CaM immunostain ing were substantially prevented by the NMDA channel antagonist CGS-\9755 which also de creased damage determined histologically (Grotta et aI., 1990) .
Recently we, as well as others, were able to show that activity of two major Ca2+ -regulated protein kinases, Ca2+ /CaM-dependent protein kinase II (CaM-KII) and protein kinase C (PKC) were dra matically decreased after ischemia whereas activity of cAMP-dependent protein kinase was not affected after this insult (Taft et aI., 1988; Churn et aI., 1990; Zivin et aI., 1990; Madden et aI., 1991; Wieloch et aI., 1991; Aronowski et aI., 1992) . Decreased kinase activities preceded histologic neuronal damage, suggesting an involvement of CaM-KII and PKC in early processes leading to ischemia-induced injury. Indeed, in vivo studies using rat and gerbil models of forebrain ischemia (Hara et aI., 1990; Asano et aI., 1991) were able to show neuroprotective effects of kinase inhibitors such as H-7, staurosporine, and HA-1077. It was hypothesized that neuroprotection with an NMDA antagonist would also prevent changes in Ca2 + -dependent protein kinase activity. In the present study, we examined the effects of DX treatment on changes in the activities of Ca2 +dependent protein kinases, CaM immunostaining, and histology in rat brain subjected to the four vessel occlusion model of global ischemia.
METHODS

Production of ischemia and treatment protocol
Male Wistar rats (22G-280 g) were used in all studies. Ischemia was induced by a modification of the four-vessel occlusion model (Pulsinelli et aI., 1982; Grotta et aI., 1990) . In brief, with rats fasted overnight with free access to water and anesthetized under chloral hydrate, the verte bral arteries were coagulated and the carotid arteries loose ly tagged. The following day the carotid arteries were occluded for 20 min using atraumatic aneurysm clips. Control (sham) animals were subjected to identical surgi cal procedures but their vessels were not occluded, and vehicle instead of drug was administered. Ischemia was verified using EEG as well as righting and corneal reflexes. During ischemia and for 1 h after ischemia, animals were kept under a heating lamp and on an electric warming blanket to retain constant brain temperature. Tempera ture was monitored from rectum (with probe inserted 6 cm deep), surface of the skull, and, in a separate series of eight animals, also caudate putamen as previously de scribed by Busto et al. (1987) using a microprobe ther mometer (Omega Engineering Inc., Model 4IOB-T and Yellowspring Instrumental, Yellowspring, OH, U.S.A.).
For histological analysis, rats were pretreated with DX or placebo (0.9% saline) 5 min before ischemia and six doses hourly thereafter. Another group received only postischemia treatment with six doses hourly beginning 30 min after ischemia. Animals were killed after 72 h. The regimen of DX treatment was the same for animals used to analyze changes in CaM immunostaining as for animals in the pretreated histology group, but the animals were killed 24 h after ischemia. Finally, rats used for kinase activity analyses were pretreated with DX or placebo 5 min before ischemia with no additional posttreatment. These rats were killed 0, 2, and 24 h after ischemia. All DX (Hoffman LaRoche, Nutley, NJ, U.S.A.) treatments were by injection into the femoral vein as a single bolus of 15 mg/kg in 0.9% saline.
Histology
For histology, animals (n = 6 for each ischemia pre and posttreated as well as placebo-treated group) were anesthetized with ether and perfused via the ascending aorta with 10% formalin in phosphate buffer. The brains were removed and stored in 10% formalin until they were embedded in paraffin. Coronal sections (7 /Lm) were stained with hematoxylin and eosin and examined by light microscopy. Parietal cortex and hippocampal regions of both hemispheres were analyzed. Each region was given a score by a blinded observer based on the percentage of neurons with shrunken eosinophilic cytoplasm and pyk notic nuclei. The scoring was via a scale from 0 to 4 (0 = no damage; 1 = 1-25%; 2 = 26-50%; 3 = 51-75%, and 4 = 76-100% of cells damaged). Statistical analysis of dif ferences in grade of neuronal damage was performed us ing Kruskal-Wallis one-way analysis of variance (ANOV A) and two-tailed t tests for evaluating group dif ferences between analyzed regions in treatment versus control animals.
Calmodulin immunostaining
Immunocytochemical staining studies were performed exactly as described previously (Picone et al., 1989) .
Briefly, animals (n = 6 for each group for placebo and DX treatment) under ether anaesthesia were perfused with 4% paraformaldehyde, decapitated, and the brain removed. Cryostat sections (40 /Lm) were obtained from brains fixed in 4% paraformaldehyde for at least 3 days. CaM was detected with affinity-purified anti-CaM poly clonal antibody that recognized only CaM unbound to Ca 2 + and target-binding proteins. A grading scale for im munostaining was based on light microscopic visualiza tion of staining intensity (evaluations were blinded). CA 1, CA-3, dentate gyrus, and parietal cerebral cortex were analyzed. The scale was from 0 to 4 [0 = no staining, 1 = minimal staining, 2 = some staining, 3 = extensive stain ing but normal neuronal soma not distinguishable, 4 = extensive staining of neuronal soma (normal)). Statistical analysis was performed using Kruskal-Wallis one-way ANOV A and two-tailed t tests similar to that used for histological analysis.
Measurement of CaM-II and PKC activity
Animals (n = 52 and 5-9 rats per group as indicated in Table 1 ) were anesthetized with ether and decapitated. Hippocampus and whole cerebral cortex were immedi ately dissected from brains and placed in ice-cold phos phate-buffered solution. The tissue was then homoge nized in buffer containing 10 mM Tris (pH 7.4), 1 mM EDTA, 1 mM EGTA, 0.5 mM dithiothreitol, 0.1 mM phe nylmethylsulfonyl fluoride, 10 mg/L leupeptin and 50 mg/L of soybean trypsin inhibitor at 1: 10 (w/v) of tissue to buffer. Since postmortem time was previously shown to effect the activity of CaM-KII (Goldenring et aI., 1983) the time between sacrificing the animal and homogenizing was kept constant and was -45 s. These homogenates were aliquoted and stored at -80°C. Samples were used only once. To assay CaM-KII and PKC activity we used 3 /Lg of protein per reaction and employed either the syn thetic peptide substrate (MHRQETVD, NTPJ) for CaM KII or histone Hfl to assay PKC as described previously (Aronowski et aI., 1992) . To activate CaM-KII we used 1 mM CaCl 2 and 1 /LM CaM, whereas to activate PKC we used 1 mM CaCI 2 , 200 /LM phosphatidylserine and 16 /LM diacylglycerol. All phosphorylation reactions were ac complished in buffer containing 0.5 mM dithiothreitol (DTT), 10 mM HEPES (pH 7.4), 5 mM MgCl 2 and 15 /LM ATP (3 /LCi [3 2 P]ATP/reaction; 3,000 Ci/mmol) for 1 min at 30°C. Reactions were terminated by spotting aliquots on phosphoceUulose filters. After washing in 75 mM o-phosphoric acid, the radioactivity on the filters was de-termined by liquid scintillation counting. The activity of each kinase was calculated from the amount of 3 2 p incor porated into substrate in the presence of activators minus that obtained without activators (in the presence of 2 mM EGTA). Statistical analyses of differences between pla cebo-and DX-treated animals were performed using two tailed t tests.
RESULTS
Physiologic parameters
There were no differences between placebo-and the DX-treated animals for any of the physiological variables during ischemia, including arterial blood pressure, EEG, corneal and righting reflexes, or brain or body core temperature. In a series of four DX and four placebo control animals subjected to 20 min of ischemia, average rectal temperature was 37.0 ± OSC for both DX-and placebo-treated an imals. Skull surface temperature during ischemia was 36.8 ± 0.3°C for DX-and 36.9 ± 0.3°C for placebo-treated rats, and temperature in the cau date putamen was 36.5 ± O.l°C for DX and 36.6 ± 0.2°C for placebo. Additionally, there was no sta tistical difference in brain temperature between pla cebo-and DX-treated rats during the first 20 min of reperfusion.
Histology
Light microscope analysis of brain tissue sections prepared from rats subjected to 20 min of forebrain ischemia and analyzed after 72 h of reperfusion, revealed regional differences in neuronal loss as previously described (Grotta et aI., 1990) . Brain ar eas exhibiting the most damage were the subiculum and CAl region of hippocampus (score = 3.67 for both subiculum and dorsal CAl and 3.25 for lateral CAl), although CA-3, CA-4, dentate, and cerebral cortex also showed significant cell loss [�50% (score = 1.5-1.8)] (Fig. 1) . DX pretreatment signif icantly protected cerebral cortex (score of 1.58 for placebo to 0.33 for DX), subiculum (3.67 to 1.83), Means ± SD of kinase activities obtained from analysis of indicated number of animals (n).
a Significance at p < 0.05 of difference in kinase activity between placebo-and dextrorphan-treated animals. As seen in Fig. 1 , the magnitude of the protection after DX treatment was similar throughout most an alyzed regions and caused about a twofold (except cerebral cortex, fourfold) decrease in histologic damage when compared with placebo-treated ani mals. In contrast to animals pretreated with DX, there was no histologic protection of neurons from ischemia in groups of animals posttreated with DX ( Fig. 2) , suggesting that the presence of DX in the brain during ischemia and before reperfusion is es sential for expression of histological protection in this model.
CaM immunostaining
Previous studies using the compettttve NMDA antagonist CGS-19755 showed that histologic brain protection was paralleled by decreased binding of Ca2+ ICaM to target proteins, presumably reflecting decreased Ca2 + influx after ischemia. If DX is pro viding a protective effect by decreasing Ca2+ in flux, a similar CaM immunostaining pattern would be expected. Twenty minutes of ischemia followed by 24 h of reperfusion in placebo-treated animals, resulted in decreased CaM immunostaining simi larly to previously presented data (Grotta et aI., 1990) . Scores were assigned to three subregions of hippocampus and cerebral cortex (Fig. 3) . A score of 0 means no immunostaining and presumably in dicates that all CaM is associated with neuronal Ca2 + ICaM-binding proteins (Picone et aI., 1989) . Reduced CaM staining indicating increased Ca2 + I CaM binding was most pronounced in the CAl re gion of hippocampus (score of 0.58) and was -20% greater than this in the least-affected dentate gyrus (score of 1.33). DX treatment significantly reduced the loss of CaM staining throughout all four ana lyzed regions, resulting in at least a twofold in crease of staining relative to placebo-treated ani mals (score of 1.92, 2.42, 3,80, and 2.17 for CAl, CA3, dentate gyrus, and cerebral cortex, respec- tively). Four out of five rats treated with DX showed full protection of CaM staining in dentate gyrus.
CaM-KII and PKC activity
Recently it was reported (Taft et aI., 1988; Zivin et aI., 1990; Aronowski et aI., 1992) that changes in Caz+ -dependent protein kinase activity after isch emia may represent a sensitive indicator of early neuronal changes. Both CaM-KII and PKC activity in this report were significantly decreased when as sayed in rat brain homogenates obtained from pla cebo-treated animals subjected to ischemia. Imme diately after 20 min of ischemia, CaM-KII activity was reduced 79 and 81% in hippocampus and cere bral cortex, respectively ( Table I) . At the same time, PKC activity was reduced by 42% in hippo campus and 26% in cerebral cortex. At 2 and 24 h of reperfusion some recovery of CaM-KII activity (to values �50% of initial activity) was detected; how ever, PKC activity remained depressed at a con stant level for 24 h.
Since DX pretreatment reduced histological dam age after ischemia and decreased the loss in CaM immunostaining, we presumed that the loss in ki nase activity would also be attenuated by DX treat ment. DX pretreatment (15 mg/kg) significantly blocked the reduction of PKC and CaM-KII activity after 20 min of ischemia and at 0 and 24 h of reper fusion (except PKC activity in cortex after 24 h) as compared with placebo-treated rats. However, the same DX treatment did not show any significant effect on either kinase activity after 2 h of reperfu sion. The magnitude of loss of CaM-KII activity with DX was similar after 0 and 24 h of reperfusion in both hippocampus and cerebral cortex. Increases of CaM-KII and PKC activity produced by DX treatment (expressed as a difference between pla cebo and DX treatment) was �25 and 13% for CaM KII and PKC, respectively, after 0 and 24 h of re circulation. Distribution of values of activities for individual animals are presented in Fig. 4A for CaM-KII and Fig. 4B for PKC.
DISCUSSION
Dextrorphan is a potent noncompetitive inhibitor of the NMDA subtype of glutamate receptors (Church et aI., 1985; Choi et aI., 1987) . DX was chosen for this study because of its favorable phar macodynamic and pharmacokinetic properties. DX readily crosses the blood-brain barrier and reaches high concentrations in the brain (Swan and Mel drum, 1990 ( Lodge and Johnson, 1990) . For example, glutamate increases 3[H]DX binding to cortical membranes (Franklin and Murray, 1990) , This suggests that the increased concentration of glutamate, like that found in the extracellular space during ischemia, increases DX binding and facilitates the block of these Ca2+ -permeable ion channels. An additional potential way that DX could block Caz+ influx is through the voltage-gated Ca2+ channel (VGCC). Jaffe et al. (1989) found that DX can reversibly dis place ligands specifically labeling VGCC. This unique mode of action, through glutamate subtype of NMDA channels as well as through VGCC, make DX an interesting tool to study the impact of Caz + influx on neuronal injury induced by cerebral isch emia. DX has already been demonstrated to protect neurons from death in several models of excitotox-
icity (Choi et aI., 1987; Goldberg et aI., 1988) and global and focal ischemia (Steinberg et al., 1988; Swan and Meldrum, 1990; Steinberg et aI., 1991) . A plausible mechanism of DX neuroprotection during ischemia is due to its inhibition of Ca2 + entry into the cell after glutamate stimulation. Indeed DX was shown to reduce Ca2+ rises in rat pyramidal neuro nal cultures evoked by NMDA receptor activation (Church et aI., 1991) , while another noncompetitive NMDA channel antagonist MK-801 inhibited accu mulation of intracellular Ca2 + after infusion of NMDA into the brain in vivo (Uematsu et aI., 1991) .
In addition to its direct effect on Ca2 + entry, it has recently been demonstrated that DX may act through the sigma receptor (Sagratella et aI., 1991) . Activation of this receptor mitigates hippocampal damage after cerebral ischemia suggesting an alter native mechanism of action for DX (Jensen and Auer, 1991) . One study showed that the N-methyl ated conjugate of DX, dextromethorphan, was as sociated with increased cerebral blood flow (CBF) but it is unclear if this was the cause or result of neuronal protection (Lo and Steinberg, 1991) . CBF was not measured in the present study. Finally, ob served changes were not due to hypothermia in duced by DX, because head and core body temper ature during ischemia in DX-treated rats was un changed from placebo-treated rats.
Unlike results obtained during incomplete isch emia in rats induced by hypovolemia and carotid occlusion (Swan and Meldrum, 1990 ), in our model of global ischemia we could not obtain any histo logic protection of animals treated with DX after complete ischemia. This result suggests that DX must be present during ischemia and reperfusion to provide protection in the four-vessel occlusion model used in our laboratory. This point may be particularly relevant since recent studies in our lab oratory demonstrate that CaM-KII activity can be reduced even further by reperfusion (Hanson et aI., 1992) . Consequently, in clinical studies of cerebral infarction the most advantageous use of glutamate antagonists may be immediately after the onset of the stroke but before the implementation of reper fusion therapy.
Recently, we demonstrated that CaM association with neuronal proteins is increased after global isch emia in rats (Picone et aI., 1989) . This finding es tablished that postischemic changes in CaM immu nostaining after 24 h of reperfusion (versus those observed after a shorter period of reperfusion) were most consistent and best correlated with histologi cal damage to vulnerable neuronal tissue (Grotta et aI., 1990) . One possible interpretation from the CaM immunostaining results is that an increase in Ca2+ concentration in the neuron, caused by pro gressively worsening imbalance in Ca2+ influx ver sus efflux after ischemia, increases formation of Ca2+ ICaM complexes which bind to Ca2+ /CaM tar get proteins, depleting the pool of free CaM. DX treatment, similarly to CGS-19755, offered signifi cant protection from loss of CaM immunostaining.
One of the major Ca2 + ICaM-regulated proteins in the brain is CaM-KII (Schulman, 1991; Kelly, 1992) . CaM-KII is recognized as an important key element in the regulation of multiple cellular pro cesses (Kelly, 1992) . High concentration of this en zyme in regions of the brain with the greatest vul nerability to ischemia together with its high postsynaptic concentrations (the postsynaptic part of the neuron is selectively injured by ischemia) makes CaM-KII a likely candidate to play an im portant role in biochemical processes leading to neuronal death after ischemia (Pulsinelli et aI., 1982; Ouimet et aI., 1984; Kelly et aI., 1984) .
Similarly to CaM-KII, PKC modulates multiple cellular processes including regulation of Ca2 + fluxes. A number of reports suggest that PKC acti vates Ca2+ -ATPase and Na + /Ca2+ exchanger, en zymes which are important in control of Ca2+ bal ance by removal of Ca2 + from the cells (Nishizuka, 1988) . Inhibition of PKC activity after several min utes of ischemia could contribute to increased Ca2+ concentration in the cell. On the other hand, initial Ca2 + influx immediately after the onset of ischemia (before down-regulation of PKC) can activate PKC causing potentiation of NMDA responses (Chen and Huang, 1992) , which may lead to further in creases in Ca2+ influx and greater damage to the cell.
Recently, several studies demonstrated down regulation of CaM-KII and PKC activity in neuro nal tissue after global ischemia in both rats and ger bils and after ischemia in the rabbit spinal cord model (Taft et aI., 1988; Wieloch et aI., 1991; Aronowski et aI., 1992) . In this current work, con sistently with our previous report, 20 min of global ischemia produced dramatic reductions in CaM-KII activity and smaller but significant decreases in PKC activity in both cerebral cortex and hippocam pus. These decreases in activity of CaM-KII and PKC were only partially reversible when assayed after 24 h of reperfusion. The mechanism(s) leading to decreased CaM-KII activity after ischemia are unknown; however, preliminary results obtained in our laboratory indicate that autoregulatory mecha nisms intrinsic to the enzyme may lead to its inac tivation. The mechanism(s) of decreased PKC ac tivity are also unknown, but autoregulatory proper ties also seem to be possible. For example, Ohno et al. (1990) suggested that autophosphorylation of the a isoform of PKC can lead to down-regulation of its activity, suggesting that excessive phosphorylation during ischemia may lead to inactivation of the en zyme.
Treatment of the rats with DX significantly pre vented the reduction of both CaM-KII and PKC activity after ischemia. This protection was ob served 0 and 24 h after ischemia. There was no effect of DX on kinase activity 2 h after ischemia. If excessive Ca2 + influx during ischemia is responsi ble for kinase down-regulation, DX (presumably acting by blocking Ca2+ influx) could inhibit this down-regulation. The reason for lack of protection of kinases after 2 h of reperfusion is unclear but may be related to pharmacokinetic factors like de creased brain DX concentration below an effective level to inhibit Ca2 + influx. Alternatively, it was shown by Uematsu et al. (1988) that there is a fur ther (above the level present during ischemia) in crease in intracellular Ca2 + concentration at the be ginning of reperfusion after ischemia, and we have found in other experiments (Hanson et al., 1992) that there is also a further reduction in CaM-KII activity during the first hour of reperfusion. Since there is no further increase of extracellular gluta mate during reperfusion, it is possible that this rise in intracellular Ca2+ may not be related to NMDA receptor activity. This may explain why postisch emic DX treatment did not have an effect on histo logical protection and kinase activities after 2 h of reperfusion. Effectiveness of DX treatment on CaM immunostaining and kinase activities, measured 24 h after reperfusion may, on the other hand, repre sent a shorter cumulative time of Ca2+ overloading in the neurons as compared with placebo-treated animals. Analogous to the above observations, an imals subjected to 10 versus 20 min of ischemia, despite indistinguishable initial down-regulation of CaM-KIl, recovered kinase activity much faster (Aronow ski et aI., 1992), suggesting that faster re covery characterizes smaller magnitude insults. Other unknown processes may also play a role.
We conclude that down-regulation of CaM-KII and PKC observed after ischemia can be partially inhibited by pretreatment of rats with DX and that this may represent a key element in cytoprotection after ischemia. The mechanisms by which protein kinases participate in ischemia-induced injury re main to be determined.
